Research Library

open-access-imgOpen AccessThe Use of Betamethasone in Women at Risk of Preterm Delivery Associated With the Incidence of Neonates Respiratory Distress Syndrome (NRDS), A Systematic Review
Author(s)
Fathi N. Alim,
Nadia Dessi Quartantri,
Rizka Ramadani
Publication year2022
Resource typeUndefined
Background : Neonatal Respiratory Disease Syndrome (NRDS) still become the most cause of neonatal’s mortality and morbidity especially in premature infants. Antenatal betamethasone has positive effect on preventing NRDS. Objectives : We sought to perform a systematic review of the use of bethametasone in women at risk of preterm delivery associated with the incidence of NRDS articles over the past fifty years. Methods: A systematic review was performed on PubMed and Scopus search term “Pediatrics” and “Pregnancy”. Results: Four articles identified between 2016 and 2019 specifically addressed for the use of betamethasone in women at risk of preterm delivery associated with the incidence of NRDS. A total 1800 patients were included in these four studies. The success rate range from 87,4% to 100%.  Conclusion: Overall, the use of betamethasone in women at risk of preterm delivery decrease the incidence of respiratory distress syndrome in newborn significantly.
Subject(s)betamethasone , biology , bronchopulmonary dysplasia , genetics , gestational age , incidence (geometry) , medicine , neonatal respiratory distress syndrome , obstetrics , optics , pediatrics , physics , pregnancy , respiratory distress , surgery
Language(s)English
DOI10.54543/kesans.v1i5.55

Seeing content that should not be on Zendy? Contact us.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here